Wayland Group Corp

PINK:MRRCF USA Drug Manufacturers - Specialty & Generic
Market Cap
$13.99K
Market Cap Rank
#47747 Global
#14726 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$3.41
About

Wayland Group Corp. produces and sells medical marijuana in Canada and internationally. The company was founded in 2013 and is based Burlington, Canada.

Wayland Group Corp - Asset Resilience Ratio

Latest as of September 2018: 0.00%

Wayland Group Corp (MRRCF) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$0.00
Cash + Short-term Investments
Total Assets
$155.03 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2017)

This chart shows how Wayland Group Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Wayland Group Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Wayland Group Corp maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Wayland Group Corp Industry Peers by Asset Resilience Ratio

Compare Wayland Group Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Wayland Group Corp (2014–2017)

The table below shows the annual Asset Resilience Ratio data for Wayland Group Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-12-31 0.00% $0.00 $74.49 Million --
2016-12-31 0.00% $0.00 $18.36 Million --
2014-12-31 0.00% $0.00 $6.64 Million --
pp = percentage points